Last reviewed · How we verify

NCT05612503

Virtual Reality and Congenital Diaphragmatic Hernia

Completed NA Last updated 10 November 2022
What this trial tests

NA trial testing Traditional physical therapy program in Virtual Reality in 52 participants. Completed in 15 April 2022.

Timeline
10 January 2021
Primary endpoint
9 September 2021
15 April 2022

Quick facts

Lead sponsorQassim University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment52
Start date10 January 2021
Primary completion9 September 2021
Estimated completion15 April 2022
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Qassim University

Who can join

Adults 6 to 10, any sex, with Virtual Reality or Congenital Diaphragmatic Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study has been designed to investigate the effect of 12 weeks of using virtual reality based exercises on pulmonary functions, exercise capacity, functional performance, and quality of life in children with surgically-repaired congenital diaphragmatic hernia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Traditional physical therapy program

Trials testing the same drug.

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

Other Qassim University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05612503.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing